The global bariatric surgery devices market size was valued at USD 2.52 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030. The growing occurrence of obesity worldwide is a major driver of the increased demand for bariatric surgery. Inactive lifestyles, diets high in calories, and urbanization, are contributing to higher rates of obesity globally. According to World Health Organization (WHO) in 2022, 2.5 billion adults aged 18 years and older were overweight, including 890 million adults who were living with obesity. About 16% of adults aged 18 years and older worldwide were obese in 2022. In 2022, an estimated 37 million children under the age of 5 years were overweight. Almost half of children under 5 years who were overweight in 2022 lived in Asia.
The increasing incidence of severe obesity globally is increasing the need for bariatric surgery devices. Moreover, childhood obesity rates are rising rapidly, putting overweight children at higher risk. Additionally, chronic diseases such as high cholesterol, hypertension, and diabetes are increasingly affecting young people. Advancements in manufacturing technologies have made the bariatric surgery devices market viable and accessible, which is further expected to contribute to market growth. Moreover, the increasing prevalence of obesity drives up the demand for bariatric surgery, thereby fostering market growth.
In 2023, the minimally invasive surgical devices emerged as the market leader, capturing the largest revenue share of 64.1%. Minimally invasive surgical devices refer to instruments, tools, and equipment used in medical procedures that involve small incisions or entry points compared to traditional open surgeries. These devices enable surgeons to perform operations with reduced trauma to the body, leading to benefits such as faster recovery times, shorter hospital stays, less pain, and lower risk of complications for patients. As a result, the rapidly increasing number of surgeries is accelerating the global demand for minimally invasive surgically devices.
The non-invasive surgical devices are anticipated to exhibit CAGR of 4.6% from 2024 to 2030. Non-invasive surgical devices are the devices that usually do not physically enter the body or damage others organs and tissue. Continuous innovation in medical technology, including advanced imaging modalities, robotics, and sophisticated instrumentation and tests such as CT scan, MRI and ECG is driving the market demand.
The sleeve gastrectomy segment dominated the market and accounted for a share of 44.0% in 2023. The increasing preference for sleeve gastrectomy is fueled by the growing demand for effective, safe, and cost-effective surgical options. This procedure has a shorter stay after surgery and lower complication rates compared to alternative methods, which are anticipated to boost market growth. In addition, its minimally invasive nature, characterized by smaller incisions, enhances patient acceptance and contributes significantly to heightened demand within the market.
Non-invasive bariatric surgery is expected to witness the fastest CAGR of 7.0% during the forecast period, owing to continuous advancements in medical technology and growing preference among patients for non-invasive treatment options due to reduced recovery times and minimized post-operative pain and scarring. In addition, the aging population and increasing prevalence of obesity-related conditions necessitate less invasive treatment options that cater to elderly patients.
Hospitals & ambulatory surgery centers dominated the market with a revenue share of 59.3% in 2023, attributable to massive increase in obese population and rising awareness of treatment approaches. Moreover, well-equipped diagnostic facilities, access to skilled healthcare professionals, and expanded health insurance coverage for hospital-based services from various private and group insurance plans.
Bariatric surgery clinics is expected to witness a significant CAGR of 5.2% during the forecast period, owing to rising global prevalence of obesity, which increases the demand for bariatric procedures and specialized clinics dedicated to bariatric surgeries. Moreover, the establishment of comprehensive care models in bariatric clinics, including pre-operative counseling, personalized treatment plans, and post-operative support, enhances patient satisfaction and outcomes, further driving demand.
In 2023, North America bariatric surgery devicesmarket emerged as the leader, capturing a significant revenue share of 41.0%, driven by growth of the country's healthcare infrastructure, increasing demand for minimally invasive surgeries, presence of device manufacturers, expansion of research and development leading to new product introductions. In 2022, there were over 10 million people in Canada who were overweight and 8.7 million who were obese, thereby creating a market opportunity in the coming years.
In 2023, the bariatric surgery devices in the U.S. emerged as a frontrunner, capturing a significant market share. Rising obesity rates in population is projected to propel the bariatric surgery market in the U.S. Additionally, the country's robust healthcare infrastructure and the substantial presence of market players are anticipated to further stimulate market expansion throughout the forecast period. According to data from the latest National Survey of Children's Health, one in six youth in U.S. have obesity.
The Europe bariatric surgery devices market, with a valuation of 698.7 million in 2023, is expected to witness a significant CAGR of 5.4% during the forecast period from 2024 to 2030. This growth can be attributed to increase in obese population, the prevalence of diabetes and heart diseases, government initiatives to curb obesity, and insurance coverage of surgeries. According to the WHO European Region Report, overweight and obesity affect almost 60% of adults and nearly one in three children (29% of boys and 27% of girls).
The bariatric surgery devices market in Germany held a prominent position in European bariatric surgical devices market, owing to increasing healthcare costs, increasing penetration of minimally invasive procedures, infrastructure, and an increasing prevalence rate of chronic diseases. Moreover, the presence of key competitors is expected to further boost market growth.
The bariatric surgery devices market in Asia Pacific is projected to witness the fastest CAGR of 6.2% during the forecast period. This growth can be attributed to various factors, owing to the rising incidence of obesity-related conditions in countries such as India, China, and Japan, along with a growing population of teenagers and adults, increasing co-morbidities such as diabetes and heart disease, and governmental efforts to address obesity.
China bariatric surgery devices market is expected to witness a significant growth during the forecast period owing to increasing various health issues such as diabetes, obesity, and cardiovascular diseases, thereby necessitating increased demand for diagnostic and treatment services.
India bariatric surgery devices is expected to witness a remarkable growth in the coming years. One of the main factors propelling the significant growth of India's market for bariatric surgical devices is the increasing prevalence of obesity and its associated health conditions such as diabetes and heart disease. India possesses a strong healthcare infrastructure, featuring numerous hospitals and clinics capable of conducting bariatric surgery.
The surge in competition is driving rapid technological progress, prompting companies to enhance their products through extensive research and development efforts. Leading companies are adopting various strategic approaches such as mergers & acquisitions, partnerships, and new product introductions to bolster their market presence.
The following are the leading companies in the bariatric surgery devices market. These companies collectively hold the largest market share and dictate industry trends.
In November 2022, Boston Scientific announced that it entered into an agreement to acquire Apollo Endosurgery, Inc. Apollo Endosurgery product portfolio includes products used while performing endoluminal surgery (ELS) procedures to manage gastrointestinal complications, close gastrointestinal defects, and helps in weight loss for patients suffering with obesity.
In May 2023, Olympus announced the market launch of POWERSEAL Sealer/Divider for Europe, Middle East & Africa. This bipolar device supports the surgeons with state-of-the-art dissection, sealing for open & laparoscopic surgical treatments.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.66 billion |
Revenue forecast in 2030 |
USD 3.64 billion |
Growth rate |
CAGR of 5.4% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Device, procedure, end use |
Regional scope |
North America, Europe, Asia Pacific, Latin America, MEA |
Country scope |
U.S., Canada, Mexico, Germany, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, South Korea, Thailand, Brazil, Argentina, South Africa, Saudi Arabia, UAE and Kuwait. |
Key companies profiled |
Apollo Endosurgery Inc ; Johnson& Johnson; Asensus Surgical; AbbVie; ReShape Lifesciences Inc. ; Medtronic Plc; Entero Healthcare; CONMED Corporation; Olympus Corporation; |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented has segmented the bariatric surgery devices market report based on device, procedure, end use, and region.
Device Outlook (Revenue, USD Million, 2018 - 2030)
Minimally Invasive Surgical Devices
Stapling Device
Energy/Vessel Sealing Devices
Suturing Devices
Accessories
Non-invasive Surgical Devices
Procedure Outlook (Revenue, USD Million, 2018 - 2030)
Sleeve Gastrectomy
Gastric Bypass
Revision Bariatric Surgery
Non-invasive Bariatric Surgery
Adjustable Gastric Banding
Mini-Gastric Bypass
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Bariatric Surgery Clinics
Hospitals & Ambulatory Surgery Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."